Clinical Trial Update: Quartet Lead and Resynchronization Therapy Options [Phase 4]

View source ↗

Summary

Phase 4 trial update on Quartet lead options for resynchronization therapy in heart failure; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2015-03-06